Supernus Pharmaceuticals Inc (NASDAQ:SUPN)

16.96
Delayed Data
As of Jul 01
 -0.02 / -0.12%
Today’s Change
7.31
Today|||52-Week Range
18.55
+104.34%
Year-to-Date
No recent news for Supernus Pharmaceuticals Inc.

Today’s Trading

Previous close16.98
Today’s open17.13
Day’s range16.81 - 17.48
Volume973,652
Average volume (3 months)1,052,651
Market cap$811.0M
Dividend yield--
Data as of 4:00pm ET, 07/01/2015

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-51.56%
Earnings growth (next 5 years)+29.00%
Revenue growth (last year)+915.43%
P/E ratio24.1
Price/Sales3.44
Price/Book10.23

Competitors

 Today’s
change
Today’s
% change
SGYPSynergy Pharmaceutic...+0.80+9.64%
COCPCocrystal Pharma Inc-0.01-0.88%
AMPHAmphastar Pharmaceut...-0.08-0.46%
TGTXTG Therapeutics Inc+0.07+0.42%
Data as of 4:14pm ET, 07/01/2015

Financials

Next reporting dateAugust 11, 2015
EPS forecast (this quarter)$0.02
Annual revenue (last year)$122.0M
Annual profit (last year)$19.9M
Net profit margin16.28%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, CEO, Director &
Secretary
Jack A. Khattar
CFO, Vice President &
Head-Investor Relations
Gregory S. Patrick
Corporate headquarters
Rockville, Maryland

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers